How to define treatment success using cholinesterase inhibitors

Saved in:
Bibliographic Details
Published inInternational journal of geriatric psychiatry Vol. 17; no. 4; pp. 388 - 390
Main Author Thal, Leon J.
Format Journal Article
LanguageEnglish
Published Chichester, UK John Wiley & Sons, Ltd 01.04.2002
Wiley
Subjects
Activities of Daily Living
Aged
Alzheimer Disease - drug therapy
Biological and medical sciences
Cholinergic system
Cholinesterase Inhibitors - pharmacology
Cholinesterase Inhibitors - therapeutic use
Cognition - drug effects
Drug Evaluation
Humans
Medical sciences
Neuropharmacology
Neurotransmitters. Neurotransmission. Receptors
Pharmacology. Drug treatments
Human
Evaluation
Nervous system diseases
Enzyme
Alzheimer disease
Psychotropic
Treatment efficiency
Enzyme inhibitor
Esterases
Antialzheimer agent
Acetylcholinesterase
Carboxylic ester hydrolases
Cerebral disorder
Senile dementia
Chemotherapy
Treatment
Nootropic agent
Central nervous system disease
Hydrolases
Clinical trial
Degenerative disease
Anticholinesterase agent
Elderly
EC 3.1.1.8
Online AccessGet full text

Cover

More Information
Bibliography:ArticleID:GPS612
istex:64C6E1427D506A6D6883D602169CC219D2DCBAAB
ark:/67375/WNG-FQ26R185-0
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
SourceType-Other Sources-1
content type line 63
ObjectType-Correspondence-1
ObjectType-Commentary-2
ISSN:0885-6230
1099-1166
DOI:10.1002/gps.612